BREAST DUCTAL CARCINOMA IN SITU
Clinical trials for BREAST DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can cutting calories help radiation fight breast cancer?
Disease control Recruiting nowThis study is testing if reducing calorie intake by 25% while receiving a highly focused, intense form of radiation before surgery helps shrink breast tumors more than radiation alone. It will involve 80 women with early-stage breast cancer. The goal is to see if this combined ap…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New program aims to level the playing field for breast cancer patients
Disease control Recruiting nowThis study is testing whether a patient navigation program can help reduce disparities in breast cancer care. The program helps newly diagnosed women understand their treatment options, connect with support services, and overcome barriers to getting care. Researchers want to see …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early trial tests vaccine to train body to fight breast cancer
Disease control Recruiting nowThis early-stage study is testing a vaccine called H2NVAC in patients with a specific type of early, non-invasive breast cancer (DCIS) that has a protein called HER2. The goal is to see if the vaccine is safe, find the right dose, and learn if it can stimulate the patient's own i…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Glowing needle aims to shine a light on hidden breast cancer
Diagnosis Recruiting nowThis study is testing a new glowing needle designed to help surgeons find and sample very small, hard-to-see lesions inside the tiny milk ducts of the breast. It aims to see if this new tool gives more accurate biopsy results during surgery compared to current methods, which coul…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: The Fourth Affiliated Hospital of China Medical University • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Personalized pill dose could sharply cut breast cancer risk
Prevention Recruiting nowThis study is testing a personalized approach to using the drug tamoxifen to prevent breast cancer in premenopausal women at higher-than-average risk. Researchers want to see if starting with a low dose and increasing it only for women who don't show a good initial response on th…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
New hope for women at high risk of breast cancer: study tests two preventive drugs
Prevention Recruiting nowThis study is testing two drugs, acolbifene and a low dose of tamoxifen, to see which is better at preventing breast cancer in premenopausal women who are at high risk. It will involve 80 women who will take one of the drugs daily for six months. Researchers will check for change…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC
-
Can a pill and fish oil stop breast cancer before it starts?
Prevention Recruiting nowThis study is testing whether a low dose of the drug tamoxifen, taken with or without high-dose omega-3 fish oil supplements, can help prevent breast cancer in women at high risk. It is for overweight or obese postmenopausal women who have specific risk factors, like a family his…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Mar 25, 2026 14:07 UTC
-
Cancer patients face double burden: disease costs soar during pandemic
Knowledge-focused Recruiting nowThis study aims to understand how the COVID-19 pandemic affects the financial burden on breast cancer patients undergoing surgery. Researchers will survey 600 patients about out-of-pocket costs, lost wages, and economic strain before and after their operations. The goal is to ide…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC
-
Free DNA tests offered to public in major cancer prevention study
Knowledge-focused Recruiting nowThis study is testing a new approach to finding people at high risk for inherited cancers. Researchers are offering free genetic testing to the general public to see if this broad screening catches more at-risk people than the current method, which only tests those with a known f…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC